Skip to main content
. Author manuscript; available in PMC: 2010 Nov 8.
Published in final edited form as: Cancer. 1991 Jul 15;68(2):289–294. doi: 10.1002/1097-0142(19910715)68:2<289::aid-cncr2820680213>3.0.co;2-2

Table 2.

Univariate Survival Analyses for All 63 Patients and for 50 Patients Surviving More Than 2 Months

Factor P value
(n = 63)
P value
(n = 50)
Extrahepatic biliary duct 0.0005* 0.0001*
Year of treatment 0.0221* 0.0229*
Transplant and postoperative radiotherapy 0.0313* 0.0413*
Total radiation dose 0.0394* 0.9882
Surgery, extent 0.0430* 0.0721
NTD2, external beam 0.0488* 0.3659
Sex 0.0714 0.0970
Systemic metastases 0.1136 0.0520
Prior liver disease 0.1404 0.1856
Initial tissue diagnosis 0.3531 0.1611
Age 0.3937 0.8909
Brachytherapy 0.4340 0.8670
Chemotherapy 0.4454 0.1143
Split-course irradiation 0.5936 0.5262
Field size 0.6502 0.6344
Lymphadenopathy 0.9376 0.4889
*

Statistical significance (P < 0.05).

Normalized total dose at 2 Gy per fraction.